|Bid||0.000 x 0|
|Ask||0.000 x 0|
|Day's Range||0.0000 - 0.0000|
|52 Week Range|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Canadian marijuana producer Hexo Corp. said early Thursday that it has been approved for listing on the NYSE American exchange, and will begin trading Jan. 23. Hexo's current over the counter listing in the U.S. is up 1.9% in Thursday trading. Hexo follows other Canadian licensed cannabis producers such as Aurora Cannabis Inc. and Canopy Growth Corp. , which have also listed on U.S. exchanges. Hexo and Molson Coors Brewing Co. have signed a joint venture to develop non-alcoholic, cannabis infused beverages. ETF Alternative Harvest ETF , which tracks a basket of pot stocks, is up less than 0.1% in midday trading.
HENDERSON, NV / ACCESSWIRE / January 11, 2019 / In 2018 the cannabis industry gained validation through several passages of law. Cannabis stocks, however, were down on the year in part because of a larger ...
CannTrust Holdings: Analysts Are Mainly Positive in January (Continued from Prior Part) ## Revenue trends In the first nine months of 2018, CannTrust Holdings’ (CNTTF) net revenues grew ~115% YoY (year-over-year) to 29.5 million Canadian dollars from 13.7 million Canadian dollars. In the third quarter, CannTrust Holdings generated net revenues of 12.6 million Canadian dollars compared to 6.1 million Canadian dollars in the same period the previous year, which reflected ~105% YoY growth. Analysts expect CannTrust Holdings to generate net revenues of 28.29 million in the fourth quarter. Analysts expect the company’s net revenues for fiscal 2018 to be ~60.64 million Canadian dollars. CannTrust Holdings’ peers in the licensed cannabis market, OrganiGram (OGRMF) and HEXO (HYYDF) generated net revenues of 12.43 million Canadian dollars and 4.9 million Canadian dollars, respectively, in fiscal 2018, which reflects ~60.54% and ~20.43% YoY growth. HEXO reported net revenues of 5.6 million Canadian dollars in the first quarter of 2019. ## Gross profit and EBITDA In the first nine months of 2018, CannTrust Holdings reported a gross profit and adjusted EBITDA of 44.8 million Canadian dollars and 1.2 million Canadian dollars, respectively—compared to 12.9 million Canadian dollars and 3.5 million Canadian dollars during the same period the previous year. In the third quarter, CannTrust Holdings’ gross profit and adjusted EBITDA were 12.5 million Canadian dollars and 557,983 Canadian dollars, respectively—compared to 5.4 million Canadian dollars and 1.9 million Canadian dollars during the same period the previous year. Continue to Next Part Browse this series on Market Realist: * Part 1 - CannTrust Holdings: Analysts Are Mainly Positive in January * Part 3 - CannTrust Holdings’ Earnings Trends and Recent Developments * Part 4 - Analyzing CannTrust Holdings’ Medical and Wholesale Business
CannTrust Holdings: Analysts Are Mainly Positive in January ## Stock performance On January 8, CannTrust Holdings’ (CNTTF) stock price closed at $5.63, which is ~3.04% growth from its close of $5.47 on January 7. On January 4, the company’s stock price grew ~4.18% to $5.36 from its close of $5.14 on January 3. On December 31, CannTrust Holdings’ stock price closed at $4.82 and reached $5.63 on January 8, which represents ~17% growth over the first five trading days of 2019. On January 8, CannTrust Holdings’ stock price closed at $5.63, which is ~29% growth from its 52-week low of $4.35 on December 24. The company hit its 52-week high of $11.97 on October 16. ## Listing on the NYSE On January 8, CannTrust Holding announced that it applied for its common shares to be listed on the NYSE. CannTrust Holdings will be listed on the NYSE after it satisfies all of the regulatory requirements and gets approval from the NYSE. According to the requirements, the company filed a Form 40-F registration statement with the SEC. ## Analysts’ recommendations Among the nine analysts tracking CannTrust Holdings in January, three recommended a “strong buy,” while six recommended a “buy.” In January, among the nine analysts tracking OrganiGram (OGRMF), three recommended a “strong buy,” while six recommended a “buy.” Among the ten analysts tracking HEXO (HYYDF), two recommended a “strong buy,” while eight recommended a “buy.” Continue to Next Part Browse this series on Market Realist: * Part 2 - CannTrust Holdings: Financial Overview in January * Part 3 - CannTrust Holdings’ Earnings Trends and Recent Developments * Part 4 - Analyzing CannTrust Holdings’ Medical and Wholesale Business
Auxly Cannabis (CBWTF) holds assets in all of the segments in the cannabis industry’s value chain. The company has three important divisions—upstream, midstream, and downstream.
Auxly Cannabis: An Overview for Investors ## Stock performance On January 7, Auxly Cannabis’ (CBWTF) stock price closed at $0.67, which is ~2.95% growth from its close of $0.65 on January 4. Auxly Cannabis’ stock price has grown consistently since December 24. On December 24, Auxly Cannabis’ stock price grew ~15.74% to $0.54 from $0.46 on December 21. On December 24, the company hit its 52-week low of $0.44. Auxly Cannabis’ stock price closed at $0.67 on January 7, which is ~52% growth from its 52-week low of $0.44 on December 24. The stock hit its 52-week high of $2.7 on January 17, 2018. ## Financials in a nutshell Auxly Cannabis reported revenues of 512,000 Canadian dollars in the third quarter. The company reported net expenses of 17.1 million Canadian dollars in the third quarter—compared to 5.2 million Canadian dollars in the third quarter of 2017. Vivo Cannabis (VVCIF) generated revenues of 4.3 million Canadian dollars in the third quarter. HEXO (HYYDF) reported revenues of $5.7 million in the first quarter of fiscal 2019. Auxly Cannabis’ net comprehensive loss in the third quarter was 4.6 million Canadian dollars—compared to 5.7 million Canadian dollars in the same period the previous year. In the first nine months of 2018, Auxly Cannabis’ net revenues were 512.00 Canadian dollars. During the same period, Auxly Cannabis reported unrealized gains and fair value changes of 7.1 million Canadian dollars. The company reported net expenses of 36.8 million Canadian dollars during the first nine months of 2018—compared to 8.3 million Canadian dollars during the same period the previous year. ## Analysts’ recommendations Among the two analysts tracking Auxly Cannabis in January 2019, one recommended a “strong buy,” while one recommended a “buy.” Continue to Next Part Browse this series on Market Realist: * Part 2 - Auxly Cannabis: Business Strategies and Financial Projections * Part 3 - Auxly Cannabis: Developments and Cash Equivalents
HEXO Gained 35% in the First Four Days of 2019 ## HEXO On the last day of 2018, we released a series urging cannabis investors to add HEXO (HEXO) (HYYDF) to their watchlists. Since then, we’ve seen the stock climb by over ~35% as of January 7. Yesterday alone, HEXO gained nearly 10% on positive notes from Beacon Securities. ## The details Beacon Securities gave HEXO stock a “buy” recommendation and a price target of 11 Canadian dollars. HEXO closed at 6.4 Canadian dollars on January 7, indicating a potential upside of 72% if the stock reaches its price target in the next 12 months. Two factors drove Beacon’s optimism. Firstly, HEXO recently completed 1 million square feet of production space and received initial licensing to deliver ~108,000 kilograms of product. Secondly, with just a handful of cannabis stocks listed on US exchanges, Beacon found value in HEXO’s plans to list in the country. Other cannabis stocks (HMMJ) currently listed in US markets include big players Tilray (TLRY), Canopy Growth (CGC) (WEED), and Cronos Group (CRON). Beacon also hinted that HEXO could be a good target for a strategic buyer possibly looking to enter the cannabis market. Next, let’s look at the outlook on HEXO’s financial performance followed by the consensus ratings on its stock. Continue to Next Part Browse this series on Market Realist: * Part 2 - What Analysts Expect for HEXO in 2019 * Part 3 - What Are the Consensus Ratings and Targets for HEXO?
CORAL GABLES, FL / ACCESSWIRE / January 8, 2019 / The beginning of the new year has already gotten off to a swift start for growth in the marijuana industry. With the new year in full swing, Leafbuyer Technologies Inc (OTC:LBUY), Emerald Health Therapeutics Inc (EMHTF), Tilray Inc (TLRY), and HEXO Corp (OTC PINK: HYYDF) (HEXO.TO) represent 4 pot stocks that are heating up on Tuesday. Leafbuyer Technologies Inc (OTC:LBUY) is a company you may not have heard of, but could greatly benefit from looking into.
CORAL GABLES, FL/ ACCESSWIRE / January 3,2019 / The way people receive health care, including how the medical field continues its integration of medical marijuana, is evolving. Premier Health Group (PHGRF) (PHGI), Namaste Technologies Inc (NXTTF) (N), MedMen Enterprises Inc (MMNFF), and HEXO Corp (OTC PINK: HYYDF) represent 4 pot stocks that are heating up on Thursday. Premier Health Group (PHGRF) (PHGI) saw impressive gains in the month of December, as the Company's shares hit highs of 0.80 to mark a move of more than 30% over the course of the 30-day period.
CORAL GABLES, FL / ACCESSWIRE / December 18, 2018 / Marijuana stocks are taking center stage this morning. A strong mix of premarket momentum and headlines are bringing pot to the forefront. As the landscape ...
On December 13, the British Columbia Supreme Court ordered the immediate shutdown of all illegal cannabis stores operating in Vancouver. The City of Vancouver had filed 53 injunctions in total against the dispensaries, which were operating outside the city’s regulations since April 2016, when the city introduced its medical marijuana related use (or MMRU) model. In regards to the ruling, Kaye Krishna, Vancouver’s general manager of development, business and licensing, said, “The ruling signals that any cannabis retail store operating outside City regulations can and will be enforced against using all the tools at the City’s disposal to the fullest extent moving forward,” according to Globalnews.ca.
HENDERSON, NV / ACCESSWIRE / December 11, 2018 / CBD-infused beverages are poised to take a hefty market share; giants like Constellation and Coca-Cola are already paying attention to this new cannabis ...
HENDERSON, NV / ACCESSWIRE / November 21, 2018 / While cannabis companies have been the 'green' stocks on investors minds for most of 2018, renewable energy companies have been making investors serious ...
Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks releases a sector snapshot with a focus on the recent JV’’s (joint ventures) and investments in the cannabis infused beverage market.
Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks releases a sector snapshot with a focus on the growing interest in cannabis infused beverages and water soluble cannabis solutions. From the news: “The focus of the Company has been to develop beverages that will distinguish our functional beverages from cannabis/ hemp beverages developed by our competitors.
CORAL GABLES, FL / ACCESSWIRE / November 6,2018 / According to Statistics Canada, there were nearly 2,400 people employed by 55 licensed marijuana producers at the end of 2017. Medical cannabis has been legal since 2001, but with the end of a 95-year prohibition on the recreational use of the drug, the number of job vacancies in the marijuana industry has exponentially increased. In a statement from Alison McMahon, founderand chief executive of the human resources firm Cannabis at Work, she explains, "The sector is moving at a breakneck speed.
HENDERSON, NV / ACCESSWIRE / October 24, 2018 / While there is quite a bit of doom and gloom on the market, some stocks look like they are set to beat the market with some big moves. A very interesting ...
HENDERSON, NV / ACCESSWIRE / October 23, 2018 / There are several stocks we see poised to breakout this week. One of the most promising opportunities is Endonovo Therapeutics, Inc. (ENDV). The company's ...
Emerging businesses often serve as excellent chances to earn outsized profits. One rising out of the shadows recently is the marijuana industry. Bans instituted in the early 20th century drove its cultivation and use of cannabis underground. However, with various trends toward legalization, marijuana stocks have gained interest from investors.
HENDERSON, NV / ACCESSWIRE / September 28, 2018 / Pot smokers have been buzzing about marijuana for years, medicinal almost as long and for the past few years investors have been loving this almost legal ...
A permissive medical marijuana law received voter approval in Oklahoma earlier this year. Also, Republicans in Texas recently approved medical marijuana in their party platform. When this status changes, investing in medically-related marijuana stocks could reach a fever pitch in the fourth quarter and beyond.
SAINT JOHN, NB , Sept. 13, 2018 /CNW/ - Momentum continues to build for the establishment of a Responsible Cannabis Framework as eight more organizations join the Global Cannabis Partnership (GCP), in its newly opened Member category. "We expect membership to expand as more and more stakeholders recognize the necessity of social responsibility policies and programs and want to be at the table to collaborate," says Kim Wilson , Executive Director of the GCP.